Skip to main content
. Author manuscript; available in PMC: 2023 Jun 30.
Published in final edited form as: Clin Biomech (Bristol). 2021 Sep 10;90:105481. doi: 10.1016/j.clinbiomech.2021.105481

Table 1. Mean (standard deviation) participant demographics and clinical intake parameters.

P-values are listed in the final column. In the top portion of the graph the P-values represent the comparison between the cohort with patellofemoral pain and the control cohort. The comparison was done for each age bracket independently. Thus, the P-value for the adult bracket is given first, then the P-value for the adolescent bracket is provided after the backslash. For the bottom portion of the graph, the P-value represents the comparison across age brackets for the cohort with patellofemoral pain.

Adult Adolescent P-Value


PFP Control PFP Control


Knees (N) 20 20 20 20 NA
Participants (n) 20 20 20 16 NA
Age (years) 28.1 (4.9) 28.0 (4.8) 13.9 (1.4) 13.8 (1.3) 0.95/0.67
  (range) 21.8-37.6 22.4-37.2 10.3-16.3 10.3- 16.0
Weight (kg) 61.4 (8.9) 60.3 (8.2) 50.1 (7.3) 50.6 (8.6) 0.71/0.84
Height (cm) 164.4 (5.8) 166.3 (7.8) 161.0 (8.0) 159.1 (10.0) 0.38/0.52
BMI (kg/m2) 22.7 (2.7) 21.8 (2.8) 19.3 (2.3) 19.9 (2.4) 0.33/0.43




J-sign (n)* 8Y/11N NA 15Y/4N NA 0.04
Q-angle (°) 16.7 (4.5) NA 13.4 (3.6) NA 0.01
Lat. Hypermobility (mm)* 6.8 (3.6) NA 7.2 (3.8) NA 0.92
Kujala Score 73.8 (14.3) NA 64.5 (12.5) NA 0.15
VAS (typical day) 37.4 (18.6) NA 43.3 (24.2) NA 0.41
VAS (during activities that invoke pain) 67.4 (22.2) NA 73.9 (18.0) NA 0.37
Length of Pain (years) 3.9 (3.0) NA 2.4 (1.9) NA 0.09
*

Unable to measure certain subject in each cohort due to positive apprehension test.